Intel and Oregon Health & Science University are collaborating to develop the Collaborative Cancer Cloud, a precision medicine analytics platform that allows hospitals and research institutions to securely share patient genomic, imaging, and clinical data for potentially lifesaving discoveries.
Intel announced that key technology components of the Collaborative Cancer Cloud (CCC) will be opened sourced. Hospitals and research institutions of all sizes could use the technology to advance cancer research, and they can also apply it to advance research in other diseases that have a genetic component, including Alzheimer’s, diabetes, Autism and more.
According to an OHSU blog post, officials say, “We expect two new institutions will be on board by 2016, addressing the critical need for larger patient pools and practitioner awareness. And from there, we can open up this federated, secure Collaborative Cancer Cloud network to dozens of others institutions—or let them create their own–to accelerate the science and the precision treatment options for clinicians to share with their patients. They can also apply it to advance personalized research in other diseases that are known to have a genetic component, including Alzheimer’s, diabetes, autism, and more.”
The post continues, “In the same timeframe, we also intend to deliver open source code contributions to ensure the broadest developer base possible is working on delivering interoperable solutions. Open sourcing this code will drive both interoperability across different clouds, and allow analytics across a broader set of data – resulting in better insights for personalized care.”